title: [The role of local surgical and radiological control in the treatment of soft tissue sarcoma sensitive to chemotherapy in children. Report of Polish Pediatric Solid Tumors Treatment Group].
abstract: In this paper the role local surgical and radiological control in the treatment of soft tissue sarcomas in children was analyzed. All children were treated according to CWS-91 and SIOP-IV protocols. Eighty three children with RMS A + E, EES/PNET, SS, UDS were included in the analysis. The primary surgery consisted of R0 (5%), R1 (18%) or R2 (16%) resection. In majority of cases (61%) primary surgical intervention was limited to diagnostic biopsy. Conventional or hyperfractionated radiotherapy was performed in 42.8%, 73.8% and 75% of children with disease stage II, III and IV, respectively. Delayed surgery was performed in 20 out of 53 (37.7%) children with stage III of the disease. In 5 patients without primary focus (urinary bladder in 3 and prostate in 2 cases) removed, progression of the disease occurred. In 5 children (stage IV) with progression of the disease no secondary surgery was performed. In 4 of them the primary tumor exceeded 10 cm in diameter. No delayed surgery was performed in 69% of relapsed children with stage III of the disease. Planned radiation therapy was not performed in 15.9% of cases. Primary local surgical control of primary tumor is of great importance for remission duration. In children who underwent delayed surgery the estimated EFS was of 0.7, in comparison with 0.5 EFS of those without secondary surgical treatment.
authors.affiliation: Kliniki Hematologii i Chorób Rozrostowych Dzieci Akademii Medycznej we Wrocławiu.
authors.forename: B
authors.initials: B
authors.lastname: Kazanowska
authors.forename: W
authors.initials: W
authors.lastname: Jaworski
authors.forename: J
authors.initials: J
authors.lastname: Godziński
authors.forename: M
authors.initials: M
authors.lastname: Jeleń
authors.forename: D
authors.initials: D
authors.lastname: Turkiewicz
authors.forename: J
authors.initials: J
authors.lastname: Toporski
authors.forename: J
authors.initials: J
authors.lastname: Armata
authors.forename: A
authors.initials: A
authors.lastname: Balcerska
authors.forename: E
authors.initials: E
authors.lastname: Drozyńska
authors.forename: P
authors.initials: P
authors.lastname: Kołecki
authors.forename: M
authors.initials: M
authors.lastname: Liebhart
authors.forename: J
authors.initials: J
authors.lastname: Melanowska
authors.forename: T
authors.initials: T
authors.lastname: Nowak
authors.forename: R
authors.initials: R
authors.lastname: Rokicka-Milewska
authors.forename: G
authors.initials: G
authors.lastname: Skotnicka
authors.forename: B
authors.initials: B
authors.lastname: Sopyło
authors.forename: M
authors.initials: M
authors.lastname: Wysocki
mesh_terms: D000293:Adolescent; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D011044:Poland; D012189:Retrospective Studies; D012509:Sarcoma / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery
chemical_list: D000970:Antineoplastic Agents